EyePoint (EYPT) Operating Margin (2010 - 2026)
EyePoint (EYPT) reported Operating Margin of 12532.47% for Q1 2026, down 1233275.0% on a YoY basis from N/an in Q1 2025, and down 10.46% sequentially from 11345.97% in Q4 2025.
EyePoint (EYPT) Operating Margin (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Operating Margin data on file, last reported at 12532.47% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 1233275.0% year-over-year to 12532.47%; the trailing twelve-month figure through Mar 2026 stood at 3700.89% (down 341295.0% YoY), and the FY2025 full-year result was 775.98%, down 43893.0% from the prior year.
- Operating Margin retreated to 12532.47% in Q1 2026, from 11345.97% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 94.71% in Q3 2023 to a low of 12532.47% in Q1 2026.
- A 5-year average of 2042.4% and a median of 285.18% in 2024 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin surged 29864 bps in 2023 and tumbled 1233275 bps in 2026, its largest moves.
- Tracing EYPT's Operating Margin over 5 years: stood at 415.22% in 2022, then jumped by 72 bps to 116.58% in 2023, then slumped by 235 bps to 390.4% in 2024, then plunged by 2806 bps to 11345.97% in 2025, then fell by 10 bps to 12532.47% in 2026.
- Business Quant data shows EYPT's Operating Margin at 12532.47% in Q1 2026, 11345.97% in Q4 2025, and 6420.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -12,532.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,532.47% |
| Dec 31, 2025 | -11,345.97% |
| Sep 30, 2025 | -6,420.81% |
| Jun 30, 2025 | -1,166.83% |
| Mar 31, 2025 | -199.72% |
| Dec 31, 2024 | -390.40% |
| Sep 30, 2024 | -311.17% |
| Jun 30, 2024 | -364.52% |
| Mar 31, 2024 | -285.18% |
| Dec 31, 2023 | -116.58% |
| Sep 30, 2023 | -94.71% |
| Jun 30, 2023 | -249.98% |
| Mar 31, 2023 | -280.54% |
| Dec 31, 2022 | -415.22% |
| Sep 30, 2022 | -183.76% |
| Jun 30, 2022 | -166.16% |
| Mar 31, 2022 | -196.73% |
| Dec 31, 2021 | -156.36% |
| Sep 30, 2021 | -169.04% |
| Jun 30, 2021 | -121.81% |